- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Urinary Tract Cancer Market, 2024 - 2032, (USD Billion)
- 2.2. Urinary Tract Cancer Market: Snapshot
- Chapter 3. Global Urinary Tract Cancer Market – Industry Analysis
- 3.1. Urinary Tract Cancer Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing consumption of cigarettes
- 3.2.2. Increasing sedentary lifestyle
- 3.3. Restraints
- 3.3.1. Lack of awareness in the developing countries
- 3.4. Opportunity
- 3.4.1. Untapped techniques for treatment of urinary tract cancer
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by Type segment
- 3.6.2. Market attractiveness analysis by Diagnostic Techniques segment
- 3.6.3. Market attractiveness analysis by Treatment segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Urinary Tract Cancer Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Urinary Tract Cancer market: company market share analysis, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Diagnostic Techniques launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- Chapter 5. Global Urinary Tract Cancer Market – Type Segment Analysis
- 5.1. Global Urinary Tract Cancer market overview: by Type
- 5.1.1. Global Urinary Tract Cancer market revenue share, by Type, 2024 and 2032
- 5.2. Squamous cell carcinoma
- 5.2.1. Global Urinary Tract Cancer market by Squamous cell carcinoma, 2024-2032 (USD Billion)
- 5.3. Adenocarcinoma
- 5.3.1. Global Urinary Tract Cancer market by Adenocarcinoma, 2024-2032 (USD Billion)
- 5.4. Urothelial carcinoma
- 5.4.1. Global Urinary Tract Cancer market by Urothelial carcinoma, 2024-2032 (USD Billion)
- 5.5. Others
- 5.5.1. Global Urinary Tract Cancer market by Others, 2024-2032 (USD Billion)
- Chapter 6. Global Urinary Tract Cancer Market – Diagnostic Techniques Segment Analysis
- 6.1. Global Urinary Tract Cancer market overview: by Diagnostic Techniques
- 6.1.1. Global Urinary Tract Cancer market revenue share, by Diagnostic Techniques, 2024 and 2032
- 6.2. Cystoscopy
- 6.2.1. Global Urinary Tract Cancer market by Cystoscopy, 2024-2032 (USD Billion)
- 6.3. Transurethral resection of tumor
- 6.3.1. Global Urinary Tract Cancer market by Transurethral resection of tumor, 2024-2032 (USD Billion)
- 6.4. Imaging tests
- 6.4.1. Global Urinary Tract Cancer market by Imaging tests, 2024-2032 (USD Billion)
- 6.5. Urine analyses
- 6.5.1. Global Urinary Tract Cancer market by Urine analyses, 2024-2032 (USD Billion)
- 6.6. Others
- 6.6.1. Global Urinary Tract Cancer market by Others, 2024-2032 (USD Billion)
- Chapter 7. Global Urinary Tract Cancer Market – Treatment Segment Analysis
- 7.1. Global Urinary Tract Cancer market overview: by Treatment
- 7.1.1. Global Urinary Tract Cancer market revenue share, by Treatment, 2024 and 2032
- 7.2. Chemotherapy
- 7.2.1. Global Urinary Tract Cancer market by Chemotherapy, 2024-2032 (USD Billion)
- 7.3. Intravesical therapy
- 7.3.1. Global Urinary Tract Cancer market by Intravesical therapy, 2024-2032 (USD Billion)
- 7.4. Radiation therapy
- 7.4.1. Global Urinary Tract Cancer market by Radiation therapy, 2024-2032 (USD Billion)
- 7.5. Surgery
- 7.5.1. Global Urinary Tract Cancer market by Surgery, 2024-2032 (USD Billion)
- Chapter 8. Global Urinary Tract Cancer Market - Regional Analysis
- 8.1. Global Urinary Tract Cancer market overview: by region
- 8.1.1. Global Urinary Tract Cancer market revenue share, by region, 2024 and 2032
- 8.2. North America
- 8.2.1. North America Urinary Tract Cancer market, by country, 2024-2032 (USD Billion)
- 8.2.2. North America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.2.3. North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.2.4. North America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.2.5.2. The U.S. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.2.5.3. The U.S. Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.2.6.2. Rest of North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.2.6.3. Rest of North America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Urinary Tract Cancer market, by country, 2024-2032 (USD Billion)
- 8.3.2. Europe Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.3.3. Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.3.4. Europe Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.3.5. U.K.
- 8.3.5.1. U.K. Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.3.5.2. U.K. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.3.5.3. U.K. Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.3.6. France
- 8.3.6.1. France Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.3.6.2. France Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.3.6.3. France Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.3.7. Germany
- 8.3.7.1. Germany Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.3.7.2. Germany Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.3.7.3. Germany Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.3.8.2. Rest of Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.3.8.3. Rest of Europe Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Urinary Tract Cancer market, by country, 2024-2032 (USD Billion)
- 8.4.2. Asia Pacific Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.4.3. Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.4.4. Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.4.5. China
- 8.4.5.1. China Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.4.5.2. China Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.4.5.3. China Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.4.6. Japan
- 8.4.6.1. Japan Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.4.6.2. Japan Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.4.6.3. Japan Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.4.7. India
- 8.4.7.1. India Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.4.7.2. India Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.4.7.3. India Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.4.8.2. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.4.8.3. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Urinary Tract Cancer market, by country, 2024-2032 (USD Billion)
- 8.5.2. Latin America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.5.3. Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.5.4. Latin America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.5.5.2. Brazil Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.5.5.3. Brazil Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.5.6.2. Rest of Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.5.6.3. Rest of Latin America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- 8.6. Middle East & Africa
- 8.6.1. Middle East & Africa Urinary Tract Cancer market, 2024-2032 (USD Billion)
- 8.6.2. Middle East & Africa Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
- 8.6.3. Middle East & Africa Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
- 8.6.4. Middle East & Africa Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
- Chapter 9. Company Profiles
- 9.1. Shionogi & Co., Ltd.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. Medical Enzymes AG
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Amgen Inc
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Spectrum pharmaceuticals.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Bristul-Myers Squibb Company
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Developments
- 9.6. F. Hoffmann-La Roche Ltd
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Developments
- 9.7. Boehringer Ingelheim GmbH
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Developments
- 9.8. IkerChem S.L
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Developments
- 9.9. Kyowa Hakko Kirin Co., Ltd.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Developments
- 9.10. Genzyme Corporation
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Developments
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Urinary Tract Cancer market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: Urinary Tract Cancer market
5. Global Urinary Tract Cancer market attractiveness, by Type
6. Global Urinary Tract Cancer market attractiveness, by Diagnostic Techniques
7. Global Urinary Tract Cancer market attractiveness, by Treatment
8. Global Urinary Tract Cancer market revenue share, by Type, 2024 and 2032
9. Global Urinary Tract Cancer market by Squamous cell carcinoma, 2024-2032 (USD Billion)
10. Global Urinary Tract Cancer market by Adenocarcinoma, 2024-2032 (USD Billion)
11. Global Urinary Tract Cancer market by Urothelial carcinoma, 2024-2032 (USD Billion)
12. Global Urinary Tract Cancer market by Others, 2024-2032 (USD Billion)
13. Global Urinary Tract Cancer market revenue share, by Diagnostic Techniques, 2024 and 2032
14. Global Urinary Tract Cancer market by Cystoscopy, 2024-2032 (USD Billion)
15. Global Urinary Tract Cancer market by Transurethral resection of tumor, 2024-2032 (USD Billion)
16. Global Urinary Tract Cancer market by Imaging tests, 2024-2032 (USD Billion)
17. Global Urinary Tract Cancer market by Urine analyses, 2024-2032 (USD Billion)
18. Global Urinary Tract Cancer market by Others, 2024-2032 (USD Billion)
19. Global Urinary Tract Cancer market revenue share, by Treatment, 2024 and 2032
20. Global Urinary Tract Cancer market by Chemotherapy, 2024-2032 (USD Billion)
21. Global Urinary Tract Cancer market by Intravesical therapy, 2024-2032 (USD Billion)
22. Global Urinary Tract Cancer market by Radiation therapy, 2024-2032 (USD Billion)
23. Global Urinary Tract Cancer market by Surgery, 2024-2032 (USD Billion)
24. Global Urinary Tract Cancer market revenue share, by region, 2024 & 2032
25. North America Urinary Tract Cancer market, 2024-2032 (USD Billion)
26. Europe Urinary Tract Cancer market, 2024-2032 (USD Billion)
27. Asia Pacific Urinary Tract Cancer market, 2024-2032 (USD Billion)
28. Latin America Urinary Tract Cancer market, 2024-2032 (USD Billion)
29. Middle East & Africa Urinary Tract Cancer market, 2024-2032 (USD Billion)
Table Of Tables
List of Tables
1. Global Urinary Tract Cancer market: snapshot
2. Drivers for Urinary Tract Cancer market: impact analysis
3. Restraints for Urinary Tract Cancer market: impact analysis
4. North America Urinary Tract Cancer market revenue, by country, 2024-2032 (USD Billion)
5. North America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
6. North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
7. North America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
8. The U.S. Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
9. The U.S. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
10. The U.S. Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
11. Rest of North America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
12. Rest of North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
13. Rest of North America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
14. Europe Urinary Tract Cancer market revenue, by country, 2024-2032 (USD Billion)
15. Europe Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
16. Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
17. Europe Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
18. U.K. Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
19. U.K. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
20. U.K. Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
21. France Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
22. France Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
23. France Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
24. Germany Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
25. Germany Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
26. Germany Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
27. Rest of Europe Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
28. Rest of Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
29. Rest of Europe Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
30. Asia Pacific Urinary Tract Cancer market revenue, by country, 2024-2032 (USD Billion)
31. Asia Pacific Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
32. Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
33. Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
34. China Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
35. China Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
36. China Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
37. Japan Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
38. Japan Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
39. Japan Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
40. India Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
41. India Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
42. India Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
43. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
44. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
45. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
46. Latin America Urinary Tract Cancer market revenue, by country, 2024-2032 (USD Billion)
47. Latin America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
48. Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
49. Latin America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
50. Brazil Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
51. Brazil Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
52. Brazil Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
53. Rest of Latin America Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
54. Rest of Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
55. Rest of Latin America Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)
56. Middle East & Africa Urinary Tract Cancer market revenue, by Type, 2024-2032 (USD Billion)
57. Middle East & Africa Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2024-2032 (USD Billion)
58. Middle East & Africa Urinary Tract Cancer market revenue, by Treatment, 2024-2032 (USD Billion)